{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:17:01Z","timestamp":1793254621533,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Parvovirus B19 (B19V) is a significant pathogen responsible for a wide range of clinical manifestations, particularly in children and pregnant women. While B19V is most commonly recognized as the cause of Fifth disease, a mild erythematous illness in children, its clinical impact extends far beyond this condition. B19V can lead to severe complications, including transient aplastic crisis in individuals with chronic hemolytic anemias, arthralgia, and more severe joint diseases. During pregnancy, B19V infection poses serious risks, such as spontaneous abortion, non-immune hydrops fetalis, and fetal anemia, particularly when infection occurs between 9 and 20 weeks of gestation. Moreover, B19V is associated with a variety of organ system involvements, including cardiac, neurological, hepatic, and renal complications. These manifestations can range from mild to life-threatening, necessitating a broad spectrum of therapeutic approaches, including symptomatic care, immunoglobulins, corticosteroids, and supportive therapies. Despite the significant clinical burden posed by B19V, no specific antiviral treatment or vaccine is currently available, making early recognition and prompt management crucial for improving patient outcomes. This review provides a comprehensive overview of the diverse clinical presentations of B19V infection, with a focus on pediatric and pregnancy-related complications. It underscores the need for ongoing research into targeted therapies and highlights the importance of vigilant clinical management to mitigate the severe consequences of this pervasive virus.<\/jats:p>","DOI":"10.1186\/s13052-024-01831-6","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T13:59:13Z","timestamp":1734530353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Parvovirus B19 infection in children: a comprehensive review of clinical manifestations and management"],"prefix":"10.1186","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2853-8318","authenticated-orcid":false,"given":"Silvia","family":"Bloise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Cocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Mambelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Radice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"issue":"24","key":"1831_CR1","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1056\/NEJMicm1807156","volume":"379","author":"M -Mende","year":"2018","unstructured":"Mende M, Sockel K. Parvovirus B19 Infection. N Engl J Med. 2018;379(24):2361. https:\/\/doi.org\/10.1056\/NEJMicm1807156.","journal-title":"N Engl J Med"},{"key":"1831_CR2","doi-asserted-by":"publisher","unstructured":"Landry ML, Parvovirus B. Microbiol Spectr. 2016;4(3). https:\/\/doi.org\/10.1128\/microbiolspec.DMIH2-0008-2015.","DOI":"10.1128\/microbiolspec.DMIH2-0008-2015"},{"key":"1831_CR3","doi-asserted-by":"publisher","unstructured":"Leung AKC, Lam JM, Barankin B, Leong KF, Hon KL. Erythema Infectiosum: A Narrative Review. Curr Pediatr Rev. 2023 Apr;28. https:\/\/doi.org\/10.2174\/1573396320666230428104619.","DOI":"10.2174\/1573396320666230428104619"},{"issue":"10","key":"1831_CR4","first-page":"763","volume":"4","author":"J -Barash","year":"2002","unstructured":"Barash J, Dushnitzky D, Sthoeger D, Bardenstein R, Barak Y. Human parvovirus B19 infection in children: uncommon clinical presentations. Isr Med Assoc J. 2002;4(10):763\u20135.","journal-title":"Isr Med Assoc J"},{"issue":"1","key":"1831_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2217\/fmb-2020-0123","volume":"16","author":"R -Cnc Garcia","year":"2021","unstructured":"Cnc Garcia R, Leon LA. Human parvovirus B19: a review of clinical and epidemiological aspects in Brazil. Future Microbiol. 2021;16(1):37\u201350. https:\/\/doi.org\/10.2217\/fmb-2020-0123.","journal-title":"Future Microbiol"},{"issue":"11","key":"1831_CR6","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.3390\/v15112261","volume":"15","author":"T -Patalon","year":"2023","unstructured":"Patalon T, Saciuk Y, Trotzky D, Pachys G, Ben-Tov A, Segal Y, et al. An Outbreak of Parvovirus B19 in Israel. Viruses. 2023;15(11):2261. https:\/\/doi.org\/10.3390\/v15112261.","journal-title":"Viruses"},{"issue":"25","key":"1831_CR7","doi-asserted-by":"publisher","first-page":"2400339","DOI":"10.2807\/1560-7917.ES.2024.29.25.2400339","volume":"29","author":"C -d\u2019Humi\u00e8res","year":"2024","unstructured":"d\u2019Humi\u00e8res C, Fouillet A, Verdurme L, Lakoussan SB, Gallien Y, Coignard C, et al. An unusual outbreak of parvovirus B19 infections, France, 2023 to 2024. Euro Surveill. 2024;29(25):2400339. ES. 2024.29.25.2400339.","journal-title":"Euro Surveill"},{"issue":"15","key":"1831_CR8","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.3390\/cells13151254","volume":"13","author":"J -Bieri","year":"2024","unstructured":"Bieri J, Suter C, Caliaro O, Bartetzko S, Bircher C, Ros C. Globoside Is an Essential Intracellular Factor Required for Parvovirus B19 Endosomal Escape. Cells. 2024;13(15):1254. https:\/\/doi.org\/10.3390\/cells13151254.","journal-title":"Cells"},{"key":"1831_CR9","unstructured":"Macri A, Crane JS, Parvoviruses. 2023 Jun 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan&#8211."},{"issue":"2","key":"1831_CR10","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1128\/CDLI.8.2.288-292.2001","volume":"8","author":"JA -Jordan","year":"2001","unstructured":"Jordan JA, Huff D, DeLoia JA. Placental cellular immune response in women infected with human parvovirus B19 during pregnancy. Clin Diagn Lab Immunol. 2001;8(2):288\u201392. https:\/\/doi.org\/10.1128\/CDLI.8.2.288-292.2001.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"12","key":"1831_CR11","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.revmed.2022.08.005","volume":"43","author":"R -Jacquot","year":"2022","unstructured":"Jacquot R, Gerfaud-Valentin M, Mekki Y, Billaud G, Jamilloux Y, S\u00e8ve P. Parvovirus B19 infections in adults. Rev Med Interne. 2022;43(12):713\u201326. https:\/\/doi.org\/10.1016\/j.revmed.2022.08.005. French. doi:.","journal-title":"Rev Med Interne"},{"issue":"4","key":"1831_CR12","doi-asserted-by":"publisher","first-page":"e160","DOI":"10.1016\/S1473-3099(22)00685-5","volume":"23","author":"TH -Mogensen","year":"2023","unstructured":"Mogensen TH, Skouboe MK, M\u00f8lle I. Successful use of interferon alfa-2a for persistent parvovirus B19 infection. Lancet Infect Dis. 2023;23(4):e160\u20135. https:\/\/doi.org\/10.1016\/S1473-3099(22)00685-5.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1831_CR13","first-page":"106","volume":"151","author":"J -Stojkovic-Filipovic","year":"2016","unstructured":"Stojkovic-Filipovic J, Skiljevic D, Brasanac D, Medenica L. Gianotti-Crosti syndrome associated with Ebstein-Barr virus and Parvovirus B-19 coinfection in a male adult: case report and review of the literature. G Ital Dermatol Venereol. 2016;151(1):106\u201311.","journal-title":"G Ital Dermatol Venereol"},{"issue":"3","key":"1831_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/ced.14070","volume":"45","author":"ASM -Tidman","year":"2020","unstructured":"Tidman ASM, Fatima R. An unusual cutaneous manifestation of parvovirus B19 infection: papular-purpuric gloves-and-socks syndrome and petechial bathing trunk eruption. Clin Exp Dermatol. 2020;45(3):341\u20132. https:\/\/doi.org\/10.1111\/ced.14070.","journal-title":"Clin Exp Dermatol"},{"issue":"8","key":"1831_CR15","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.3390\/microorganisms12081708","volume":"12","author":"R -Arvia","year":"2024","unstructured":"Arvia R, Stincarelli MA, Manaresi E, Gallinella G, Zakrzewska K. Parvovirus B19 in Rheumatic Diseases. Microorganisms. 2024;12(8):1708. https:\/\/doi.org\/10.3390\/microorganisms12081708.","journal-title":"Microorganisms"},{"issue":"4","key":"1831_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/00002281-200007000-00010","volume":"12","author":"TL -Moore","year":"2000","unstructured":"Moore TL. Parvovirus-associated arthritis. Curr Opin Rheumatol. 2000;12(4):289\u201394. https:\/\/doi.org\/10.1097\/00002281-200007000-00010.","journal-title":"Curr Opin Rheumatol"},{"key":"1831_CR17","first-page":"576","volume":"16","author":"I -Speyer","year":"1998","unstructured":"Speyer I, Breedveld FC, Dijkmans BA. Human parvovirus B19 infection is not followed by inflammatory joint disease during long term follow-up. A retrospective study of 54 patients. Clin Exp Rheumatol. 1998;16:576\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"1831_CR18","first-page":"1336","volume":"34","author":"B -Gonzalez","year":"2007","unstructured":"Gonzalez B, Larranaga C, Leon O, Diaz P, Miranda M, Barria M, et al. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis. J Rheumatol. 2007;34(6):1336\u201340.","journal-title":"J Rheumatol"},{"issue":"2","key":"1831_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/s1386-6532(01)00247-5","volume":"25","author":"HW -Lehmann","year":"2002","unstructured":"Lehmann HW, K\u00fchner L, Beckenlehner K, M\u00fcller-Godeffroy E, Heide KG, K\u00fcster RM, et al. Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence. J Clin Virol. 2002;25(2):135\u201343. https:\/\/doi.org\/10.1016\/s1386-6532(01)00247-5.","journal-title":"J Clin Virol"},{"issue":"4","key":"1831_CR20","doi-asserted-by":"publisher","first-page":"R82","DOI":"10.1186\/ar2281","volume":"9","author":"B -Weissbrich","year":"2007","unstructured":"Weissbrich B, S\u00fcss-Fr\u00f6hlich Y, Girschick HJ. Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis. Arthritis Res Ther. 2007;9(4):R82. https:\/\/doi.org\/10.1186\/ar2281.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1831_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1128\/CMR.00040-16","volume":"30","author":"J -Qiu","year":"2017","unstructured":"Qiu J, S\u00f6derlund-Venermo M, Young NS. Human Parvoviruses. Clin Microbiol Rev. 2017;30(1):43\u2013113. https:\/\/doi.org\/10.1128\/CMR.00040-16.","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"1831_CR22","doi-asserted-by":"publisher","first-page":"e8995","DOI":"10.7759\/cureus.8995","volume":"12","author":"NS -Nandu","year":"2020","unstructured":"Nandu NS, Hafzah H, Patel C. Parvovirus-Induced Transient Aplastic Crisis in a Patient With Newly Diagnosed Hereditary Spherocytosis. Cureus. 2020;12(7):e8995. https:\/\/doi.org\/10.7759\/cureus.8995.","journal-title":"Cureus"},{"issue":"5","key":"1831_CR23","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3390\/v15051124","volume":"15","author":"DP -Mendes-de-Almeida","year":"2023","unstructured":"Mendes-de-Almeida DP, Bokel JPB, Alves ADR, Vizzoni AG, Tavares ICF, Silva MST, et al. Clinical Presentation of Parvovirus B19 Infection in Adults Living with HIV\/AIDS: A Case Series. Viruses. 2023;15(5):1124. https:\/\/doi.org\/10.3390\/v15051124.","journal-title":"Viruses"},{"key":"1831_CR24","doi-asserted-by":"publisher","unstructured":"Silva Furtado -dosSB, Viana M, Hickson Rrios MB, Gontijo JS, Silva RL, Val Rezende CM et al. P,. Prevalence and incidence of erythrovirus B19 infection in children with sickle cell disease: The impact of viral infection in acute clinical events. J Med Virol. 2016;88(4):588\u2009\u2013\u200995. https:\/\/doi.org\/10.1002\/jmv.24378","DOI":"10.1002\/jmv.24378"},{"issue":"1","key":"1831_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s41182-020-00284-x","volume":"48","author":"S -Soltani","year":"2020","unstructured":"Soltani S, Zakeri A, Tabibzadeh A, Zandi M, Ershadi E, Akhavan Rezayat S, et al. A literature review on the parvovirus B19 infection in sickle cell anemia and \u03b2-thalassemia patients. Trop Med Health. 2020;48(1):96. https:\/\/doi.org\/10.1186\/s41182-020-00284-x.","journal-title":"Trop Med Health"},{"issue":"6","key":"1831_CR26","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1002\/jmv.26734","volume":"93","author":"T -Lampejo","year":"2021","unstructured":"Lampejo T. Parvovirus B19 infection as a potential trigger for fat embolism syndrome in patients with sickle cell disease. J Med Virol. 2021;93(6):3283\u20134. https:\/\/doi.org\/10.1002\/jmv.26734.","journal-title":"J Med Virol"},{"key":"1831_CR27","unstructured":"Mangla A, Hamad H, Pure Red Cell A. 2024 Feb 24. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan."},{"issue":"5","key":"1831_CR28","doi-asserted-by":"publisher","first-page":"E64","DOI":"10.1111\/j.1399-3062.2012.00773.x","volume":"14","author":"C -Gosset","year":"2012","unstructured":"Gosset C, Viglietti D, Hue K, Antoine C, Glotz D, Pillebout E. How many times can parvovirus B19-related anemia recur in solid organ transplant recipients? Transpl Infect Dis. 2012;14(5):E64\u201370. https:\/\/doi.org\/10.1111\/j.1399-3062.2012.00773.x.","journal-title":"Transpl Infect Dis"},{"issue":"9","key":"1831_CR29","doi-asserted-by":"publisher","first-page":"e13535","DOI":"10.1111\/ctr.13535","volume":"33","author":"AJ -Eid","year":"2019","unstructured":"Eid AJ, Ardura MI, AST Infectious Diseases Community of Practice. Human parvovirus B19 in solid organ transplantation: Guidelines from the American society of transplantation infectious diseases community of practice. Clin Transpl. 2019;33(9):e13535. https:\/\/doi.org\/10.1111\/ctr.13535.","journal-title":"Clin Transpl"},{"issue":"5","key":"1831_CR30","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.autrev.2004.10.004","volume":"4","author":"L -Mouthon","year":"2005","unstructured":"Mouthon L, Guillevin L, Tellier Z. Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia. Autoimmun Rev. 2005;4(5):264\u20139. https:\/\/doi.org\/10.1016\/j.autrev.2004.10.004.","journal-title":"Autoimmun Rev"},{"issue":"12","key":"1831_CR31","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/ejhf.665","volume":"18","author":"J -Verdonschot","year":"2016","unstructured":"Verdonschot J, Hazebroek M, Merken J, Debing Y, Dennert R, Brunner-La Rocca HP, Heymans S. Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature. Eur J Heart Fail. 2016;18(12):1430\u201341. https:\/\/doi.org\/10.1002\/ejhf.665.","journal-title":"Eur J Heart Fail"},{"key":"1831_CR32","doi-asserted-by":"publisher","first-page":"908663","DOI":"10.3389\/fcvm.2022.908663","volume":"9","author":"FB -Sozzi","year":"2022","unstructured":"Sozzi FB, Gherbesi E, Faggiano A, Gnan E, Maruccio A, Schiavone M, et al. Viral Myocarditis: Classification, Diagnosis, and Clinical Implications. Front Cardiovasc Med. 2022;9:908663. https:\/\/doi.org\/10.3389\/fcvm.2022.908663.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"1831_CR33","doi-asserted-by":"publisher","first-page":"e21726","DOI":"10.7759\/cureus.21726","volume":"14","author":"S Keramari","year":"2022","unstructured":"Keramari S, Poutoglidis A, Chatzis S, Keramaris M, Savopoulos C, Kaiafa G. Parvovirus B19-Associated Myocarditis: A Literature Review of Pediatric Cases. Cureus. 2022;14(1):e21726. https:\/\/doi.org\/10.7759\/cureus.21726.","journal-title":"Cureus"},{"key":"1831_CR34","doi-asserted-by":"publisher","unstructured":"Das BB, Prusty BK, Niu J, Huang ML, Zhu H, Eliassen E, et al. Detection of parvovirus B19 and human herpesvirus 6 in pediatric dilated cardiomyopathy: Impact after heart transplantation. Ann Pediatr Cardiol. 2020 Oct-Dec;13(4):301\u20138. https:\/\/doi.org\/10.4103\/apc.APC_124_19.","DOI":"10.4103\/apc.APC_124_19"},{"key":"1831_CR35","doi-asserted-by":"publisher","first-page":"e007405","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405","volume":"13","author":"E -Ammirati","year":"2020","unstructured":"Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, et al. Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ Heart Fail. 2020;13:e007405. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.120.007405.","journal-title":"Circ Heart Fail"},{"key":"1831_CR36","doi-asserted-by":"publisher","unstructured":"Drucker NA, Colan SD, Lewis AB, Beiser AS, Wessel DL, Takahashi M, et al. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation. 1994;89:252\u20137. https:\/\/doi.org\/10.1161\/01.cir.89.1.252.","DOI":"10.1161\/01.cir.89.1.252"},{"issue":"2","key":"1831_CR37","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3851\/IMP1516","volume":"15","author":"R -Dennert","year":"2010","unstructured":"Dennert R, Velthuis S, Schalla S, Eurlings L, van Suylen RJ, van Paassen P, et al. Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load. Antivir Ther. 2010;15(2):193\u2013201. https:\/\/doi.org\/10.3851\/IMP1516.","journal-title":"Antivir Ther"},{"issue":"5","key":"1831_CR38","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1007\/s00431-022-04406-x","volume":"181","author":"R -Esmel-Vilomara","year":"2022","unstructured":"Esmel-Vilomara R, Dolader P, Izquierdo-Blasco J, Balcells J, Sorl\u00ed M, Escudero F, et al. Parvovirus B19 myocarditis in children: a diagnostic and therapeutic approach. Eur J Pediatr. 2022;181(5):2045\u201353. https:\/\/doi.org\/10.1007\/s00431-022-04406-x.","journal-title":"Eur J Pediatr"},{"issue":"8","key":"1831_CR39","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3390\/biomedicines12081909","volume":"12","author":"L -Pelzl","year":"2024","unstructured":"Pelzl L, Mantino S, Sauter M, Manuylova T, Vogel U, Klingel K. Lymphocytic Myocarditis in Children with Parvovirus B19 Infection: Pathological and Molecular Insights. Biomedicines. 2024;12(8):1909. https:\/\/doi.org\/10.3390\/biomedicines12081909.","journal-title":"Biomedicines"},{"issue":"5","key":"1831_CR40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1056\/NEJM199508033330501","volume":"333","author":"JW -Mason","year":"1995","unstructured":"Mason JW, O\u2019Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med. 1995;333(5):269\u201375. https:\/\/doi.org\/10.1056\/NEJM199508033330501.","journal-title":"N Engl J Med"},{"issue":"2","key":"1831_CR41","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s00246-019-02258-1","volume":"41","author":"A -Howard","year":"2020","unstructured":"Howard A, Hasan A, Brownlee J, Mehmood N, Ali M, Mehta S, et al. Pediatric Myocarditis Protocol: An Algorithm for Early Identification and Management with Retrospective Analysis for Validation. Pediatr Cardiol. 2020;41(2):316\u201326. https:\/\/doi.org\/10.1007\/s00246-019-02258-1.","journal-title":"Pediatr Cardiol"},{"issue":"3","key":"1831_CR42","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.hfc.2005.06.004","volume":"1","author":"LT -Cooper Jr","year":"2005","unstructured":"Cooper LT Jr. Giant cell and granulomatous myocarditis. Heart Fail Clin. 2005;1(3):431\u20137. https:\/\/doi.org\/10.1016\/j.hfc.2005.06.004.","journal-title":"Heart Fail Clin"},{"issue":"9","key":"1831_CR43","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00392-016-0986-9","volume":"105","author":"HP -Schultheiss","year":"2016","unstructured":"Schultheiss HP, Piper C, Sowade O, Waagstein F, Kapp JF, Wegscheider K, et al. Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-\u03b2 treatment in patients with chronic viral cardiomyopathy. Clin Res Cardiol. 2016;105(9):763\u201373. https:\/\/doi.org\/10.1007\/s00392-016-0986-9.","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"1831_CR44","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s00246-012-0468-4","volume":"34","author":"KM -Molina","year":"2013","unstructured":"Molina KM, Garcia X, Denfield SW, Fan Y, Morrow WR, Towbin JA, et al. Parvovirus B19 myocarditis causes significant morbidity and mortality in children. Pediatr Cardiol. 2013;34(2):390\u20137. https:\/\/doi.org\/10.1007\/s00246-012-0468-4.","journal-title":"Pediatr Cardiol"},{"issue":"2","key":"1831_CR45","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/archdischild-2014-308080","volume":"101","author":"TV -Vigneswaran","year":"2016","unstructured":"Vigneswaran TV, Brown JR, Breuer J, Burch M. Parvovirus B19 myocarditis in children: an observational study. Arch Dis Child. 2016;101(2):177\u201380. https:\/\/doi.org\/10.1136\/archdischild-2014-308080.","journal-title":"Arch Dis Child"},{"issue":"7","key":"1831_CR46","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.healun.2010.03.003","volume":"29","author":"JP -Breinholt","year":"2010","unstructured":"Breinholt JP, Moulik M, Dreyer WJ, Denfield SW, Kim JJ, Jefferies JL, et al. Viral epidemiologic shift in inflammatory heart disease: the increasing involvement of parvovirus B19 in the myocardium of pediatric cardiac transplant patients. J Heart Lung Transpl. 2010;29(7):739\u201346. https:\/\/doi.org\/10.1016\/j.healun.2010.03.003.","journal-title":"J Heart Lung Transpl"},{"key":"1831_CR47","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/rmv.388","volume":"13","author":"F -Barah","year":"2003","unstructured":"Barah F, Vallely PJ, Cleator GM, Kerr JR. Neurological manifestations of human parvovirus B19 infection. Rev Med Virol. 2003;13:185\u201399. https:\/\/doi.org\/10.1002\/rmv.388.","journal-title":"Rev Med Virol"},{"issue":"4","key":"1831_CR48","doi-asserted-by":"publisher","first-page":"126","DOI":"10.5409\/wjcp.v4.i4.126","volume":"4","author":"T -Watanabe","year":"2015","unstructured":"Watanabe T, Kawashima H. Acute encephalitis and encephalopathy associated with human parvovirus B19 infection in children. World J Clin Pediatr. 2015;4(4):126\u201334. https:\/\/doi.org\/10.5409\/wjcp.v4.i4.126.","journal-title":"World J Clin Pediatr"},{"key":"1831_CR49","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1067\/mpd.2001.117070","volume":"139","author":"KJ -Wierenga","year":"2001","unstructured":"Wierenga KJ, Serjeant BE, Serjeant GR. Cerebrovascular complications and parvovirus infection in homozygous sickle cell disease. J Pediatr. 2001;139:438\u201342. https:\/\/doi.org\/10.1067\/mpd.2001.117070.","journal-title":"J Pediatr"},{"issue":"3","key":"1831_CR50","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/00006454-199903000-00025","volume":"18","author":"F -Martin\u00f3n-Torres","year":"1999","unstructured":"Martin\u00f3n-Torres F, Seara MJ, Del R\u00edo Pastoriza I, Mata MB, Castro-Gago M. Parvovirus B19 infection complicated by peripheral facial palsy and parotitis with intraparotid lymphadenitis. Pediatr Infect Dis J. 1999;18(3):307\u20138. https:\/\/doi.org\/10.1097\/00006454-199903000-00025.","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"1831_CR51","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1086\/599042","volume":"48","author":"M -Douvoyiannis","year":"2009","unstructured":"Douvoyiannis M, Litman N, Goldman DL. Neurologic manifestations associated with parvovirus B19 infection. Clin Infect Dis. 2009;48(12):1713\u201323. https:\/\/doi.org\/10.1086\/599042.","journal-title":"Clin Infect Dis"},{"key":"1831_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-19-6909-6_2","volume-title":"Pediatric Solid Organ Transplantation","author":"L -Peruzzi","year":"2023","unstructured":"Peruzzi L, Cocchi E. Transplant Immunobiology. In: Shapiro R, Sarwal MM, Raina R, Sethi SK, editors. Pediatric Solid Organ Transplantation. Singapore: Springer; 2023. https:\/\/doi.org\/10.1007\/978-981-19-6909-6_2."},{"issue":"1","key":"1831_CR53","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12985-024-02380-4","volume":"21","author":"R -Jia","year":"2024","unstructured":"Jia R, Cao L, Lu L, Zhong H, Xu M, Liu P, Zhu X, Su L, Xu J. Distinct clinical features of transplanted children with Parvovirus B19 infection. Virol J. 2024;21(1):108. https:\/\/doi.org\/10.1186\/s12985-024-02380-4.","journal-title":"Virol J"},{"issue":"2","key":"1831_CR54","doi-asserted-by":"publisher","first-page":"e14028","DOI":"10.1111\/tid.14028","volume":"25","author":"M -Holterhus","year":"2023","unstructured":"Holterhus M, Hennies M, Hillmann H, Thorer H, Rossig C, Burkhardt B, et al. Parvovirus B19 infection in pediatric allogeneic hematopoietic cell transplantation - Single-center experience and review. Transpl Infect Dis. 2023;25(2):e14028. https:\/\/doi.org\/10.1111\/tid.14028.","journal-title":"Transpl Infect Dis"},{"issue":"10","key":"1831_CR55","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1007\/s00467-024-06378-6","volume":"39","author":"M -Sabanci","year":"2024","unstructured":"Sabanci M, Ta\u015fdemir M, \u00d6ks\u00fcz B, Altuner Torun Y, S\u00fct\u00e7\u00fc M, \u00d6zkaya O. Managing recurrent parvovirus B19-associated anemia after a pediatric kidney transplant. Pediatr Nephrol. 2024;39(10):2923\u20135. https:\/\/doi.org\/10.1007\/s00467-024-06378-6.","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"1831_CR56","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/ncpneph0609","volume":"3","author":"M -Waldman","year":"2007","unstructured":"Waldman M, Kopp JB. Parvovirus-B19-associated complications in renal transplant recipients. Nat Clin Pract Nephrol. 2007;3(10):540\u201350. https:\/\/doi.org\/10.1038\/ncpneph0609.","journal-title":"Nat Clin Pract Nephrol"},{"issue":"5","key":"1831_CR57","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/s0168-8278(97)80334-0","volume":"27","author":"N -Assy","year":"1997","unstructured":"Assy N, Rosenthal E, Hazani A, Etzioni A, Baruch Y. Human parvovirus B19 infection associated with idiopathic thrombocytopenic purpura in a child following liver transplantation. J Hepatol. 1997;27(5):934\u20136. https:\/\/doi.org\/10.1016\/s0168-8278(97)80334-0.","journal-title":"J Hepatol"},{"key":"1831_CR58","doi-asserted-by":"publisher","first-page":"472027","DOI":"10.1155\/2013\/472027","volume":"2013","author":"C Bihari","year":"2013","unstructured":"Bihari C, Rastogi A, Saxena P, Rangegowda D, Chowdhury A, Gupta N, et al. Parvovirus b19 associated hepatitis. Hepat Res Treat. 2013;2013:472027. https:\/\/doi.org\/10.1155\/2013\/472027.","journal-title":"Hepat Res Treat"},{"issue":"4","key":"1831_CR59","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.transproceed.2019.01.084","volume":"51","author":"A Islek","year":"2019","unstructured":"Islek A, Keskin H, Ag\u0131n M, Aksungur N, Korkut E, Ozturk G. Parvovirus B19 Infection as a Rare Cause of Fulminant Liver Failure: A Case Report. Transpl Proc. 2019;51(4):1169\u201371. https:\/\/doi.org\/10.1016\/j.transproceed.2019.01.084.","journal-title":"Transpl Proc"},{"issue":"4","key":"1831_CR60","doi-asserted-by":"publisher","first-page":"238","DOI":"10.5414\/CN108694","volume":"85","author":"H -Marco","year":"2016","unstructured":"Marco H, Guermah I, Matas L, Hern\u00e1ndez A, Navarro M, Lopez D, et al. Postinfectious glomerulonephritis secondary to Erythrovirus B19 (Parvovirus B19): case report and review of the literature. Clin Nephrol. 2016;85(4):238\u201344. https:\/\/doi.org\/10.5414\/CN108694.","journal-title":"Clin Nephrol"},{"issue":"3","key":"1831_CR61","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s00467-002-1056-2","volume":"18","author":"Y -Ohtomo","year":"2003","unstructured":"Ohtomo Y, Kawamura R, Kaneko K, Yamashiro Y, Kiyokawa N, Taguchi T, et al. Nephrotic syndrome associated with human parvovirus B19 infection. Pediatr Nephrol. 2003;18(3):280\u20132. https:\/\/doi.org\/10.1007\/s00467-002-1056-2.","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"1831_CR62","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3390\/jpm14020139","volume":"14","author":"FP -Dittmer","year":"2024","unstructured":"Dittmer FP, Guimar\u00e3es CM, Peixoto AB, Pontes KFM, Bonasoni MP, Tonni G, et al. Parvovirus B19 Infection and Pregnancy: Review of the Current Knowledge. J Pers Med. 2024;14(2):139. https:\/\/doi.org\/10.3390\/jpm14020139.","journal-title":"J Pers Med"},{"issue":"9","key":"1831_CR63","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3390\/children11091037","volume":"11","author":"O -Olejniczak","year":"2024","unstructured":"Olejniczak O, Kornacki J, Boro\u0144 D, Gutaj P, Iciek R, Wender-O\u017cegowska E. Parvovirus B19 Infection in Pregnancy-Course of the Disease, Fetal Complications and Management Tools: A Case Series and Literature Review. Child (Basel). 2024;11(9):1037. https:\/\/doi.org\/10.3390\/children11091037.","journal-title":"Child (Basel)"},{"issue":"7","key":"1831_CR64","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/jcu.20613","volume":"37","author":"S -Borna","year":"2009","unstructured":"Borna S, Mirzaie F, Hanthoush-Zadeh S, Khazardoost S, Rahimi-Sharbaf F. Middle cerebral artery peak systolic velocity and ductus venosus velocity in the investigation of nonimmune hydrops. J Clin Ultrasound. 2009;37(7):385\u20138. https:\/\/doi.org\/10.1002\/jcu.20613.","journal-title":"J Clin Ultrasound"},{"key":"1831_CR65","unstructured":"Palasanthiran P, Starr M, Jones C, Giles M, editors. Management of Perinatal Infections; Australasian Society for Infectious Diseases (ASID): Sydney, Australia,2022;https:\/\/www.mshc.org.au\/images\/downloads\/ASIDManagementOfPerinatalInfections3rdEdition.pdf"},{"issue":"6","key":"1831_CR66","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1515\/JPM.2005.100","volume":"33","author":"H -Matsuda","year":"2005","unstructured":"Matsuda H, Sakaguchi K, Shibasaki T, Takahashi H, Kawakami Y, Furuya K. Intrauterine therapy for parvovirus B19 infected symptomatic fetus using B19 IgG-rich high titer gammaglobulin. J Perinat Med. 2005;33(6):561\u20133. https:\/\/doi.org\/10.1515\/JPM.2005.100.","journal-title":"J Perinat Med"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-024-01831-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-024-01831-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-024-01831-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T02:03:51Z","timestamp":1734573831000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-024-01831-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1831"],"URL":"https:\/\/doi.org\/10.1186\/s13052-024-01831-6","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"15 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"261"}}